Surgical Robots Market - By Component, By Application, By End Use - Global Forecast, 2025-2034

Surgical Robots Market Size

The global surgical robots market was valued at USD 8.1 billion in 2024. The market is expected to reach from USD 9.2 billion in 2025 to USD 38.4 billion in 2034, growing at a CAGR of 17.2% during the forecast period, according to the latest report published by Global Market Insights Inc. The high market growth is attributed to the rising demand for minimally invasive surgeries, growing prevalence of chronic diseases, technological advancements in robotic systems, rising healthcare expenditure and hospital investments, among other contributing factors.
 

Surgical robots are computer-assisted medical programs that allow surgeons, with the help of these devices, to perform complicated operations of the minimally invasive type with precision, control, and flexibility to a larger extent. They integrate robot arms, cameras, and specialized instruments to facilitate accuracy while improving patient outcomes, reducing recovery times, and minimizing surgical complications.
 

Some of the leading players in the surgical robots market are ACCURAY, INTUITIVE, Medtronic, and Stryker. These companies operate through continuous component innovation, global market presence, and large investments in research and development, which are the sources of their competitive strength.
 

The market has increased from USD 5.8 billion in 2021 and reached USD 7.1 billion in 2023, with the historic growth rate of 11.9%. The market growth was driven by the rising demand for minimally invasive procedures, technological advancements in robotics and AI, and increasing adoption across hospitals to enhance precision, patient outcomes, and recovery times.
 

Moreover, the increasing prevalence of cancer, cardiovascular diseases, and orthopedic disorders has driven higher surgical volumes worldwide. For instance, according to the World Health Organization (WHO), cancer cases are projected to rise by 77% in low- and middle-income countries by 2024. The American Heart Association reported that cardiovascular diseases affected 48% of adults in the U.S. in 2023, with approximately 1.2 million cardiac procedures performed annually.
 

The adoption of robotic-assisted systems has grown as they enable physicians to perform complex surgical procedures with greater precision and safety. The Centers for Disease Control and Prevention (CDC) data shows that orthopedic surgeries increased by 23% between 2021 and 2023, with over 450,000 procedures utilizing robotic assistance.
 

Furthermore, continuous innovation, such as the integration of AI, haptic feedback, and advanced imaging, is improving accuracy and reducing surgeon fatigue. These innovations make robotic platforms more reliable, scalable, and adaptable across various surgical specialties.
 

Surgical Robots Market Trends

The market is growing considerably with the expansion beyond general surgery, surging need for integrated artificial intelligence in healthcare and data analytics, growth of the robot-as-a-service (RaaS) model, and increasing role of telesurgery and remote collaboration, among other factors collectively driving industry growth.
 

• The adoption of surgical robots is expanding across medical specialties, including orthopedics, neurosurgery, gynecology, urology, and cardiac procedures. According to the FDA, the number of approved surgical robotic systems increased from 15 in 2021 to 28 by the end of 2023.
   
• The American Hospital Association reported that 72.6% of U.S. hospitals had at least one surgical robot in 2023, up from 54.3% in 2021. This expansion in clinical applications is generating additional revenue opportunities for manufacturers, with Medicare reimbursements for robot-assisted procedures increasing by 35% between 2021 and 2023.
   
• High upfront costs remain a challenge, leading to rising popularity of RaaS and leasing models. This approach allows smaller hospitals and outpatient centers to access advanced robotic systems without heavy capital investment, boosting market penetration.
   
• Further, manufacturers are developing compact, flexible, and cost-efficient robotic systems that require smaller operating rooms and simpler setups. This miniaturization trend is making surgical robotics more accessible and practical in a wider range of healthcare settings, thereby sustaining market growth.
   

Surgical Robots Market Analysis

Based on the component, the surgical robots market is segmented into robot systems and instruments and accessories. The instruments and accessories segment has asserted its dominance in the market by securing a significant market share of 68% in 2024 owing to their recurring use in every surgical procedure, continuous product upgrades, and the rising volume of robot-assisted surgeries requiring replacements and consumables.
 

On the other hand, the robot systems segment is expected to grow with a CAGR of 16%. The growth of this segment is driven by their high demand as the core component of surgical robotics, offering advanced functionality, precision, and long-term value for hospitals through repeat usage and integration across multiple procedures.
 

• The instruments and accessories segment continues to dominate the market. Unlike robotic systems that are one-time capital purchases, the instruments and accessories have to be regularly replaced after a limited number of uses. Such a business creates a strong recurring revenue flow, thus a stable demand and market growth.
   
• As the number of robotic-assisted surgeries rises in different medical fields, the consumption of the instruments, such as staplers, scissors, forceps, and energy devices, also goes up. Therefore, the increase in surgical volume is directly linked to the rise of the utilization of disposable and reusable accessories.
   
• Moreover, customized instruments designed for cardiology, neurology, orthopedics, and urology enhance precision and ease of surgery. Growing demand for such specialty-focused accessories strengthens their role in improving clinical outcomes and widening application areas.
   
• The robot systems segment held a revenue of USD 2.6 billion in 2024, with projections indicating a steady expansion at 16% CAGR from 2025 to 2034. The segmental growth is driven by their critical role as the central platform enabling advanced surgical procedures with superior precision, control, and flexibility.
   
• Growing adoption of minimally invasive surgeries and rising demand for multi-specialty applications further strengthen their utilization across hospitals. Additionally, continuous technological innovations, coupled with the integration of AI and imaging, are enhancing system efficiency and expanding their clinical appeal.
   

Based on application, the surgical robots market is segmented into general surgery, gynecology surgery, urologic surgery, orthopedic surgery, neurosurgery, and others applications. The general surgery segment dominated the market in 2024, accounting for USD 2.4 billion and is anticipated to grow at a CAGR of 18.1% during the forecast period.
 

• General surgery covers a wide range of common procedures such as hernia repair, cholecystectomy, appendectomy, and bariatric surgery. The popularity of these surgeries around the world is indirectly responsible for the demand of the use of robotic systems for the purpose of improving efficiency and patient outcomes.
   
• Both patients and doctors opt for the minimally invasive route by using the latest technologies due to the fact that such procedures are faster in terms of recovery, take less time in the hospital, and have minimal complications. The use of surgical robots is very advantageous in that they allow for better precision and clearer visualization, which in turn makes even complicated general surgical interventions possible.
   
• Moreover, improved robotic systems with advanced imaging, haptic feedback, and instrument dexterity make general surgical procedures more accurate and efficient. These innovations are expanding the scope of robotic adoption within general surgery.
   
• The gynecology surgery segment accounted for significant revenue in 2024 and is anticipated to grow at a CAGR of 17% over the forecast period. The growth of the segment is driven by the rising prevalence of conditions such as uterine fibroids, endometriosis, and gynecologic cancers that require advanced surgical interventions. The preference for robotic-assisted techniques in hysterectomies and fertility-related procedures is also growing, as they offer reduced complications, faster recovery, and improved reproductive outcomes.
   
• The urologic surgery segment accounted for significant revenue in 2024, with projections indicating a steady expansion at 17.5% CAGR from 2025 to 2034. The segmental growth is driven by the increasing incidence of prostate cancer, kidney disorders, and urinary tract diseases requiring precise interventions. The demand is further fueled by robotic systems’ ability to enhance accuracy in delicate urologic procedures, minimize complications, and preserve critical functions such as continence and sexual health.
   
• The orthopedic surgery segment held a revenue of USD 1.1 billion in 2024, with projections indicating a steady expansion at 16.6% CAGR from 2025 to 2034. Owing to the rising global burden of musculoskeletal disorders and the growing demand for joint replacement procedures in aging populations. Robotic systems enable highly accurate implant positioning and alignment, which improves long-term outcomes and reduces revision surgery rates, making them increasingly attractive to hospitals and patients.
   
• The neurosurgery segment accounted for significant revenue in 2024, with projections indicating a steady expansion at 16.1% CAGR from 2025 to 2034. The segmental growth is driven by the need for extreme precision in treating complex brain and spinal disorders, where even minor errors can lead to severe complications. The integration of robotics with advanced imaging and navigation technologies enhances surgical accuracy, reduces invasiveness, and supports better neurological outcomes.
   

Based on end use, the surgical robots market is classified into hospitals and ambulatory surgical centers. The hospitals segment dominated the market with a revenue share of 72.4% in 2024 and is expected to reach USD 28.4 billion within the forecast period.
 

• There has been a considerable increase in the investment of surgical robots by hospitals in order to accomplish better patient outcomes, such as fewer complications, quick recovery, and a shorter duration of hospitalization. The better outcomes amplify patient satisfaction, as well as the hospital's reputation, which is very important in the competitive healthcare markets.
   
• Possession of advanced robotic systems allows hospitals to differentiate themselves from competitors. Offering robotic-assisted surgeries attracts more patients, particularly those seeking high-precision, minimally invasive procedures, and establishes the hospital as a center of excellence.
   
• Further, increasing hospital budgets and willingness to invest in high-end technology support the adoption of surgical robots. Favorable reimbursement policies in key markets further reduce financial barriers and make such investments more attractive.
   
• The ambulatory surgical centers segment held a revenue of USD 2.2 billion in 2024, with projections indicating a steady expansion at 16.4% CAGR from 2025 to 2034. Ambulatory surgical centers (ASCs) are increasingly implementing surgical robots to meet the demand for minimally invasive procedures that are the trend due to patient recovery time and hospital stay reduction. The cost-efficiency of robotic-assisted surgeries makes ASCs attract a larger pool of patients, thus optimizing resource utilization.
   
• Additionally, the evolution of the small and multi-purpose robotic platform makes it suitable for the outpatient setting where the space is limited. The awareness of the patients and their demand for high-precision and low-complication procedures are the main factors behind the continuous integration of surgical robots in ASCs.
   

North America Surgical Robots Market
 

North America dominated the market with the highest market share of 59.1% in 2024.
 

• The U.S. market was valued at USD 3.3 billion and USD 3.6 billion in 2021 and 2022, respectively. The market size reached USD 4.5 billion in 2024, growing from USD 4 billion in 2023, and is anticipated to grow at a CAGR of 15.9% between 2025 to 2034.
   
• North America, particularly the U.S., has a strong culture of adopting cutting-edge medical technologies. Hospitals and surgical centers are quick to implement robotic-assisted surgical systems to improve precision, reduce complications, and enhance patient outcomes, driving steady market growth.
   
• Moreover, the region experiences increasing cases of cancer, cardiovascular diseases, obesity, and other lifestyle-related conditions requiring surgical procedures. For instance, according to the American Cancer Society, approximately 1.9 million new cancer cases were reported in 2022, while the CDC reported that 42.4% of adults were obese in 2021.
   
• The American Heart Association documented 130.2 million adults with cardiovascular diseases in 2023. Healthcare providers increasingly use robotic systems for minimally invasive surgeries to improve outcomes in high-risk patients, with over 1.4 million robotic procedures performed in North America in 2023.
   
• Further, major surgical robotics manufacturers such as Intuitive Surgical, Medtronic, and Johnson & Johnson are headquartered or have strong operations in North America. Their localized presence ensures better training, support, and supply of instruments, fostering higher adoption rates.
   

Europe Surgical Robots Market
 

Europe market accounted for USD 1.5 billion in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• European countries, such as Germany, France, and the UK, have brought in new programs to not only renovate hospitals but also facilitate the use of advanced surgical technologies. In 2023, the German Federal Ministry of Health allocated about USD 3.5 billion in funding for hospital digitalization through the Hospital Future Act (KHZG).
   
• Similarly, France allocated USD 2.9 billion for hospital improvement in 2022 as part of its Health Innovation 2030 strategy. The UK government made public a funding package of nearly USD 2.5 billion in 2021 for the NHS hospital modernization and the purchase of new equipment. Such government grants and funding schemes lower the initial capital expenditure; thus, hospitals are able to make investments in robotic surgical systems.
   
• Moreover, healthcare professionals in the area focus on minimally invasive interventions as a way of decreasing hospital stays and enhancing patient recovery. The use of robots in surgeries increases the accuracy, reduces the occurrence of errors during the operation, and is in line with the region’s requirements for top-quality care.
   

Asia Pacific Surgical Robots Market
 

The Asia Pacific surgical robots market is anticipated to grow at the highest CAGR of 19.6% during the analysis timeframe.
 

• Many Asia-Pacific countries, including China, India, and South Korea, have plans to extend their hospital networks and specialty surgical centers considerably. This upsurge in the health sector is the kind of opportunity opening for the healthcare industry to install advanced surgical robots to be able to handle the increasing demands of health services.
   
• In the Asia-Pacific region, rising income levels and increased awareness of advanced medical treatments are driving patient demand for high-quality surgical care. According to the World Bank, the average disposable income in Southeast Asia increased by 5.2% in 2022, while China reported a 4.8% growth in per capita disposable income in 2023.
   
• The popularity of robotic-assisted surgeries is increasing among patients as they are accurate and less intrusive, and the patient recuperates in less time. The Japanese Ministry of Health data show that from 2021 to 2023, the number of robotic surgeries performed increased by 42%. At the same time, South Korea's statistics show that over the same period, a 38% increase in the adoption of robotic surgery across the major hospitals has been recorded.
   

Latin America Surgical Robots Market
 

The Latin America market is experiencing robust growth over the analysis timeframe.
 

• In Latin America, the surgical robots market is primarily driven by the modernization of healthcare infrastructure across key countries such as Brazil, Mexico, and Argentina, with hospitals increasingly investing in advanced technologies to improve surgical outcomes. Rising healthcare expenditure and supportive government initiatives, including subsidies and import incentives for medical devices, are lowering adoption barriers.
   
• The growing prevalence of chronic and lifestyle-related diseases, such as cancer and cardiovascular disorders, is increasing demand for minimally invasive surgeries. Expansion of private hospitals and specialty surgical centers, combined with the rising middle-class population seeking high-quality care, is further fueling market growth.
   
• Additionally, collaborations between local healthcare providers and international medtech companies are facilitating technology transfer and training programs. Finally, awareness of robotic surgery’s benefits among both patients and surgeons is steadily increasing adoption across the region.
   

Middle East and Africa Surgical Robots Market
 

The Middle East and Africa (MEA) market is experiencing robust growth over the analysis timeframe.
 

• The regional growth is driven by significant investments in healthcare infrastructure, particularly in countries like Saudi Arabia, UAE, and South Africa, where governments are modernizing hospitals and establishing advanced surgical centers. Rising government initiatives and public-private partnerships aimed at improving healthcare quality are facilitating the adoption of robotic systems.
   
• The growing prevalence of chronic diseases, including cancer and cardiovascular conditions, is increasing the need for precision surgeries and minimally invasive procedures. Medical tourism is expanding in the region, with hospitals leveraging robotic surgery to attract international patients seeking advanced care.
   
• Additionally, increasing training programs for surgeons and collaborations with global medtech companies are enhancing clinical expertise and confidence in robotic-assisted procedures. Awareness among patients about improved surgical outcomes and faster recovery times is also encouraging wider acceptance of surgical robots across MEA.
   

Surgical Robots Market Share

The market is highly concentrated, with a few major players dominating global sales and technology innovation. Companies compete on factors such as technological advancements, range of surgical applications, pricing strategies, and geographic reach.
 

Key players include ACCURAY, INTUITIVE, Medtronic, and Stryker, collectively accounting for 93.4% of the total market share. These companies maintain a strong presence through continuous product development, strategic partnerships, and expansion into emerging markets, making it challenging for smaller players to gain significant traction.
 

The market is also characterized by increasing mergers, acquisitions, and collaborations between established medtech companies and technology firms to enhance robotic capabilities, integrate AI, and expand specialty-specific solutions. Regional players are emerging in Asia-Pacific and Latin America, focusing on cost-effective platforms to improve accessibility.
 

Innovation in instruments, accessories, and software upgrades further intensifies competition, while hospitals and surgical centers increasingly consider service quality, training support, and post-sale maintenance when selecting a vendor. The overall competitive scenario reflects a combination of high entry barriers, technological differentiation, and a focus on global expansion.
 

Surgical Robots Market Companies

Few of the prominent players operating in the surgical robots industry include:

• ACCURAY
• ASENSUS SURGICAL
• CASCINATION
• CMR SURGICAL
• Distalmotion
• ELMED MEDICAL SYSTEMS
• GLOBUS MEDICAL
• INTUITIVE
• Medtronic
• meerecompany
• RENISHAW
• Smith & Nephew
• Stryker
• THINK SURGICAL
• ZIMMER BIOMET
   
• Intuitive
   
• leading the surgical robots market with a 83.5% share in 2024,  leads the market with its da Vinci Surgical System, renowned for high precision, reliability, and a broad range of clinical applications. Its extensive global installed base and strong support ecosystem enhance surgeon adoption and recurring revenue from instruments and services.
   
• Stryker

Stryker’s Mako robotic platform is a key differentiator in orthopedic surgeries, offering precise joint replacement and bone alignment. Integration with Stryker implants and strong hospital partnerships enhances procedural efficiency and clinical outcomes.
 

• Medtronic

Medtronic’s robotic systems focus on neurosurgery and spine applications, emphasizing advanced imaging integration and navigation capabilities. Its technology improves surgical accuracy, reduces complications, and supports minimally invasive procedures across complex specialties.
 

Surgical Robots Industry News:

• In February 2024, CMR Surgical launched vLimeLite, a new imaging technology designed to visualize ICG (Indocyanine green), as part of the Versius Plus system, representing a significant enhancement to the existing platform. This release strengthens CMR Surgical's position in the market by offering enhanced surgical capabilities, improved patient outcomes, and a competitive edge over rival surgical robotics providers.
   
• In January 2024, Distalmotion partnered with Proximie, a global health technology platform digitizing operating rooms, to extend the reach of its Dexter robotic surgery platform globally. This collaboration is expected to enable increased customer base and higher revenue in coming years.
   
• In August 2021, Globus Medical, Inc. announced that Excelsius3D, an advanced intraoperative 3-in-1 imaging system, received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Excelsius3D operates as a sophisticated standalone imaging unit or seamlessly integrates with the Excelsius ecosystem. This approval expanded the product portfolio of the Excelsius ecosystem, enhancing the company's competitive position.
   
• In February 2022, Medtronic announced first clinical procedure with Hugo robotic-assisted surgery system in Europe. It includes wristed instruments, 3D visualization, and Touch Surgery Enterprise i.e., cloud-based video capture. This helped the company to introduce innovative real solutions of robotic-assisted surgery and build a strong position in the market.
   

The surgical robots market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Billion from 2021 - 2034 for the following segments:

Market, By Component

• Robot systems
• Instruments and accessories

Market, By Application

• General surgery
• Gynecology surgery
• Urologic surgery
• Orthopedic surgery
• Neurosurgery
• Others applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE